By targeting a highly conserved master controller sequence, Tune Therapeutics' lead candidate TUNE-401 can epigenetically silence all forms of the...
Gene-editing systems, especially CRISPR-Cas9, have revolutionised genome editing, offering potential cures for genetic disorders, cancers, and other...
Webinar
Webinar | Wednesday November 22, 2023 | 3:00 pm–4:00 pm CET / 9:00 am–10:00 am EDT
Leading epigeneticist Gabriella Ficz has used CRISPR technology to investigate the interplay between DNA methylation and cancer. Her latest findings...
The power of epigenetic engineering has now been used to prove that epigenetic modifications in genes expressed in the amygdala can cause alcohol use...
Epigenome editing with CRISPR is one of the new kids on the block. Dr. Nikolajs Zeps, adjunct professor at Monash University and partner at Chrysalis...
